New approaches to the pharmacological management of major depressive disorder (Q37709574)

22 August 2017

1 reference

title

New approaches to the pharmacological management of major depressive disorder (English)

1 reference

22 August 2017

Jeffrey M Witkin

1

1 reference

22 August 2017

Xia Li

series ordinal

2

1 reference

22 August 2017

publication date

27 November 2009

1 reference

22 August 2017

published in

Advances in Pharmacology

1 reference

22 August 2017

volume

57

1 reference

22 August 2017

page(s)

347-379

1 reference

Brain-derived neurotrophic factor-induced gene expression reveals novel actions of VGF in hippocampal synaptic plasticity

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

A role for AMPA receptors in mood disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

In-vitro and in-vivo characterization of JNJ-7925476, a novel triple monoamine uptake inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Depression-like behaviour in neural cell adhesion molecule (NCAM)-deficient mice and its reversal by an NCAM-derived peptide, FGL.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Chronic antidepressant treatments increase basic fibroblast growth factor and fibroblast growth factor-binding protein in neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Chronic AMPA receptor potentiator (LY451646) treatment increases cell proliferation in adult rat hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Endocannabinoids in the treatment of mood disorders: evidence from animal models

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

The cannabinoid CB1receptor and the endocannabinoid anandamide: possible antidepressant targets

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Lack of efficacy of melanin-concentrating hormone-1 receptor antagonists in models of depression and anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Regulation of CRE-dependent transcription by presenilins: prospects for therapy of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Antidepressant-like effects of mGluR1 and mGluR5 antagonists in the rat forced swim and the mouse tail suspension tests.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Antidepressant effects of ketamine in depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Aripiprazole augmentation in major depressive disorder: a double-blind, placebo-controlled study in patients with inadequate response to antidepressants

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Carbamazepine is an inhibitor of histone deacetylases

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Therapeutic potential of positive AMPA modulators and their relationship to AMPA receptor subunits. A review of preclinical data

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

AMPA receptors in the therapeutic management of depression

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Anti-depressant like effect of curcumin and its combination with piperine in unpredictable chronic stress-induced behavioral, biochemical and neurochemical changes

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

The melanin-concentrating hormone system of the rat brain: an immuno- and hybridization histochemical characterization

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Antidepressant-like activity of the fatty acid amide hydrolase inhibitor URB597 in a rat model of chronic mild stress

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

AMPA Receptor Trafficking at Excitatory Synapses

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Galanin receptor subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

New Substances of Plant Origin which Increase Nonspecific Resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Antidepressant effects of pramipexole, a dopamine D3/D2 receptor agonist, and 7-OH-DPAT, a dopamine D3 receptor agonist, in olfactory bulbectomized rats

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Tianeptine: a novel atypical antidepressant that may provide new insights into the biomolecular basis of depression

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Anxiolytic- and antidepressant-like profile of ATC0065 and ATC0175: nonpeptidic and orally active melanin-concentrating hormone receptor 1 antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Endocannabinoids mediate the effects of acute stress and corticosterone on sex behavior

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Curcumin-induced degradation of PKC delta is associated with enhanced dentate NCAM PSA expression and spatial learning in adult and aged Wistar rats

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Mirtazapine: a review of its use in major depression and other psychiatric disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Assessing antidepressant activity in rodents: recent developments and future needs

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Efficacy of the MCHR1 antagonist N-[3-(1-{[4-(3,4-difluorophenoxy)phenyl]methyl}(4-piperidyl))-4-methylphenyl]-2-methylpropanamide (SNAP 94847) in mouse models of anxiety and depression following acute and chronic administration is independent of hi

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Utility of atypical antipsychotics in the treatment of resistant unipolar depression

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

A review of the preclinical and clinical evidence for protein kinase C as a target for drug development for bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Lateral hypothalamic neuropeptides in reward and drug addiction

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

The endocannabinoid system: its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Lack of NMDA-AMPA interaction in antidepressant-like effect of CGP 37849, an antagonist of NMDA receptor, in the forced swim test

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Dysregulation of the fibroblast growth factor system in major depression

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Cannabinoids biology: the search for new therapeutic targets

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

FGF acts as a co-transmitter through adenosine A(2A) receptor to regulate synaptic plasticity

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized, placebo-controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Preclinical evaluation of melanin-concentrating hormone receptor 1 antagonism for the treatment of obesity and depression

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

The hypothalamic neuropeptide melanin-concentrating hormone acts in the nucleus accumbens to modulate feeding behavior and forced-swim performance.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Curcumin as "Curecumin": from kitchen to clinic.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Effects of the cannabinoid CB1 receptor antagonist rimonabant in models of emotional reactivity in rodents

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Deep brain stimulation of the subcallosal cingulate gyrus for depression: anatomical location of active contacts in clinical responders and a suggested guideline for targeting

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Emerging role of glutamate in the pathophysiology of major depressive disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Fish consumption and major depression

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Pharmacological enhancement of cannabinoid CB1 receptor activity elicits an antidepressant-like response in the rat forced swim test

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Involvement of the endocannabinoid system in the ability of long-term tricyclic antidepressant treatment to suppress stress-induced activation of the hypothalamic-pituitary-adrenal axis.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Estrogen recruits the endocannabinoid system to modulate emotionality

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Locus coeruleus neurons in the rat containing neuropeptide Y, tyrosine hydroxylase or galanin and their efferent projections to the spinal cord, cerebral cortex and hypothalamus

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Antidepressant actions of the exercise-regulated gene VGF.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Altered HDAC5 and CREB mRNA expressions in the peripheral leukocytes of major depression.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Angiogenic factors in patients with current major depressive disorder comorbid with borderline personality disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

AMPA receptor stimulation mediates the antidepressant-like effect of a group II metabotropic glutamate receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Neurobiological and clinical effects of the antidepressant tianeptine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Onset and early behavioral effects of pharmacologically different antidepressants and placebo in depression

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Effects of pramipexole on the duration of immobility during the forced swim test in normal and ACTH-treated rats

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Antidepressant activity of memory-enhancing drugs in the reduction of submissive behavior model

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Structure-based design leads to the identification of lithium mimetics that block mania-like effects in rodents. possible new GSK-3beta therapies for bipolar disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Antidepressant activity of curcumin: involvement of serotonin and dopamine system

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Possible involvement of L-arginine-nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) signaling pathway in the antidepressant activity of berberine chloride

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

On the mechanism of antidepressant-like action of berberine chloride

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Current investigational drugs for major depression

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Potential medicinal plants for CNS disorders: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Positive modulation of AMPA receptors increases neurotrophin expression by hippocampal and cortical neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Regulation of BDNF expression in primary neuron culture by LY392098, a novel AMPA receptor potentiator

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Antidepressant-like actions of an AMPA receptor potentiator (LY392098).

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Enhancement of antidepressant potency by a potentiator of AMPA receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Metabotropic glutamate 5 receptor antagonism is associated with antidepressant-like effects in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Antidepressant-like effects of curcumin on serotonergic receptor-coupled AC-cAMP pathway in chronic unpredictable mild stress of rats

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Antidepressant-like pharmacological profile of a novel triple reuptake inhibitor, (1S,2S)-3-(methylamino)-2-(naphthalen-2-yl)-1-phenylpropan-1-ol (PRC200-SS)

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

St John's wort for depression: meta-analysis of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Ketamine and the next generation of antidepressants with a rapid onset of action

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Targeting glutamatergic signaling for the development of novel therapeutics for mood disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

An AMPA receptor potentiator modulates hippocampal expression of BDNF: an in vivo study

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

The role of glutamate in mood disorders: results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effects

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Chronic antidepressant treatment increases the membrane expression of AMPA receptors in rat hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Imipramine treatment up-regulates the expression and function of mGlu2/3 metabotropic glutamate receptors in the rat hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Synergism between fluoxetine and the mGlu2/3 receptor agonist, LY379268, in an in vitro model for antidepressant drug-induced neurogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Distribution of galaninlike immunoreactivity in the rat central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Antidepressant treatments induce the expression of basic fibroblast growth factor in cortical and hippocampal neurons

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Fluoxetine and olanzapine have synergistic effects in the modulation of fibroblast growth factor 2 expression within the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Regulation of rat cortical 5-hydroxytryptamine2A receptor-mediated electrophysiological responses by repeated daily treatment with electroconvulsive shock or imipramine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Glutamate modulators as novel interventions for mood disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Dual- and triple-acting agents for treating core and co-morbid symptoms of major depression: novel concepts, new drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: III. Actions in models of potential antidepressive and anxiolytic activity in comparison with ropinirole

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Modulation of fibroblast growth factor-2 by stress and corticosteroids: from developmental events to adult brain plasticity

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Central side-effects of therapies based on CB1 cannabinoid receptor agonists and antagonists: focus on anxiety and depression

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Evaluation of fatty acid amide hydrolase inhibition in murine models of emotionality

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Gene profile of electroconvulsive seizures: induction of neurotrophic and angiogenic factors.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Regulation of neurogenesis and angiogenesis in depression

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Functional expression of brain neuronal CB2 cannabinoid receptors are involved in the effects of drugs of abuse and in depression

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Animal models of depression: are there any?

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Adaptogens exert a stress-protective effect by modulation of expression of molecular chaperones

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Pharmacology of Schisandra chinensis Bail.: an overview of Russian research and uses in medicine.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Glutamate and depression: clinical and preclinical studies

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Mood disorders: regulation by metabotropic glutamate receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606, in patients with treatment-refractory major depressive disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Interactions between endocannabinoids and stress-induced decreased sensitivity to natural reward

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Emerging targets for antidepressant therapies

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Intraventricular galanin produces a time-dependent modulation of 5-HT1A receptors in the dorsal raphe of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Histone deacetylase 5 epigenetically controls behavioral adaptations to chronic emotional stimuli

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Omega-3 fatty acids as treatments for mental illness: which disorder and which fatty acid?

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

GSK-3 is a viable potential target for therapeutic intervention in bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Arousal-enhancing properties of the CB1 cannabinoid receptor antagonist SR 141716A in rats as assessed by electroencephalographic spectral and sleep-waking cycle analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Differential effects of venlafaxine in the treatment of major depressive disorder according to baseline severity

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

The dietary polyphenols trans-resveratrol and curcumin selectively bind human CB1 cannabinoid receptors with nanomolar affinities and function as antagonists/inverse agonists

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Antidepressant-like and anorectic effects of the cannabinoid CB1 receptor inverse agonist AM251 in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Melanin-concentrating hormone MCH1 receptor antagonists: a potential new approach to the treatment of depression and anxiety disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

AMPA receptors: a target for novel antidepressants?

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Triple reuptake inhibitors ("broad spectrum" antidepressants).

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Preclinical and clinical pharmacology of DOV 216,303, a "triple" reuptake inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

"Broad spectrum" antidepressants: is more better for the treatment of depression?

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Glutamate-based antidepressants: 20 years on.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Mesolimbic dopamine super-sensitivity in melanin-concentrating hormone-1 receptor-deficient mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Melanin-concentrating hormone-1 receptor modulates neuroendocrine, behavioral, and corticolimbic neurochemical stress responses in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Endocannabinoid system involvement in brain reward processes related to drug abuse

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Involvement of AMPA receptor phosphorylation in antidepressant actions with special reference to tianeptine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Involvement of striatal and extrastriatal DARPP-32 in biochemical and behavioral effects of fluoxetine (Prozac).

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Anxiolytic- and antidepressant-like profiles of the galanin-3 receptor (Gal3) antagonists SNAP 37889 and SNAP 398299.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Glutamate receptors as targets of protein kinase C in the pathophysiology and treatment of animal models of mania

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Chronic treatment with AMPA receptor potentiator Org 26576 increases neuronal cell proliferation and survival in adult rodent hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Neuropeptides in depression: role of VGF

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

The neuropeptide VGF produces antidepressant-like behavioral effects and enhances proliferation in the hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Brain reward regulated by AMPA receptor subunits in nucleus accumbens shell

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Dual monoamine modulation for improved treatment of major depressive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

An integrated analysis of olanzapine/fluoxetine combination in clinical trials of treatment-resistant depression

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Functional antagonists at the NMDA receptor complex exhibit antidepressant actions

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Efficacy of omega-3 fatty acid supplementation on improvement of bipolar symptoms: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

The fibroblast growth factor system and mood disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

The fibroblast growth factor system is downregulated following social defeat

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Antidepressant-like effects of intracerebroventricular FGF2 in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Targeting glial physiology and glutamate cycling in the treatment of depression

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Tianeptine: a review of its use in depressive disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Curcumin protects against glutamate excitotoxicity in rat cerebral cortical neurons by increasing brain-derived neurotrophic factor level and activating TrkB.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

The antidepressant effects of curcumin in the forced swimming test involve 5-HT1 and 5-HT2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

The validity of animal models of predisposition to depression

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Metabotropic glutamate receptors in the control of mood disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

A therapeutic role for cannabinoid CB1 receptor antagonists in major depressive disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

A role for cannabinoid CB1 receptors in mood and anxiety disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Curcumin reverses impaired hippocampal neurogenesis and increases serotonin receptor 1A mRNA and brain-derived neurotrophic factor expression in chronically stressed rats

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Curcumin reverses the effects of chronic stress on behavior, the HPA axis, BDNF expression and phosphorylation of CREB.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Antidepressant effects of curcumin in the forced swim test and olfactory bulbectomy models of depression in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

The effects of curcumin on depressive-like behaviors in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Curcumin reverses impaired cognition and neuronal plasticity induced by chronic stress

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Galanin attenuates basal and antidepressant drug-induced increase of extracellular serotonin and noradrenaline levels in the rat hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Cellular plasticity cascades: targets for the development of novel therapeutics for bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

Tianeptine: an antidepressant with memory-protective properties

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957009-8

7 January 2021

10.1016/S1054-3589(08)57009-8

Identifiers

DOI

1 reference

22 August 2017

1 reference